Bromantane: The Dual Mechanism Nootropic from Soviet Military Science
Last updated: March 2026
Bromantane is an actoprotector developed at the Russian Academy of Medical Sciences in the 1980s that simultaneously reduces anxiety and enhances motivation. Unlike stimulants that deplete dopamine stores, it upregulates tyrosine hydroxylase — the rate-limiting enzyme in dopamine synthesis — causing the brain to produce more dopamine. It gained international attention after athletes used it at the 1996 Atlanta Olympics.
Since Development
+ Psychostimulant
After Olympic Use
📋 On this page
What Is Bromantane?
Bromantane (also Bromantan, brand name Ladasten) is an adamantane-based compound developed at the Russian Academy of Medical Sciences in the 1980s. It was designed as an "actoprotector" — a class of performance enhancers that boost physical and mental capacity without the excitatory side effects of classic stimulants. It was widely used by Soviet military personnel and later by Russian Olympic athletes, leading to a WADA ban in 1996.
Bromantane upregulates tyrosine hydroxylase (TH) — the rate-limiting enzyme in dopamine synthesis. This causes the brain to PRODUCE more dopamine from L-tyrosine, rather than dumping existing dopamine stores (like amphetamines) or blocking reuptake (like cocaine). The result is sustainable motivation without depletion. (Morozov et al., Pharm Biochem Behav 2001, PMID: 11274763)
Simultaneously upregulates tryptophan hydroxylase — the rate-limiting enzyme in serotonin synthesis. This contributes to Bromantane's anxiolytic (anti-anxiety) properties. Unlike benzodiazepines that suppress the CNS, Bromantane increases serotonin production without sedation, creating a calm-but-alert baseline.
The unique dual profile: psychostimulant effects from dopamine upregulation + anxiolytic effects from serotonin upregulation. Most anxiolytics cause sedation. Most stimulants cause anxiety. Bromantane does neither — classified by researchers as a "psychostimulant-anxiolytic" with no analogue in Western pharmacology. (Lapin et al., Pharm Biochem Behav 1993)
As a true actoprotector, Bromantane increases physical performance under extreme conditions — heat stress, hypoxia, high workload — without the cardiovascular strain of stimulants. Studied for military applications where performance must be maintained in hostile environments. Non-addictive at standard doses with no reported tolerance buildup in research literature.
What the Research Shows
Data from published studies on Bromantane's mechanisms, performance effects, and safety profile.
Research context: Most Bromantane research comes from Russian institutions. Animal and human studies exist, but Western replication is limited. The WADA ban itself is evidence of observed real-world performance effects in elite athletes.
Bromantane vs. Modafinil
Two popular nootropics with very different mechanism profiles. Understanding which fits your use case matters.
- Upregulates dopamine SYNTHESIS (sustainable)
- Dual: anxiolytic + psychostimulant simultaneously
- Improves mood baseline, reduces social anxiety
- Best for motivation, drive, emotional resilience
- Actoprotective — physical performance under stress
- No appetite suppression reported
- WADA banned — not for competitive athletes
- No human RCT data outside Russia
- Primary mechanism: dopamine REUPTAKE inhibition
- Promotes wakefulness via orexin system
- Excellent for sustained focus and task-locking
- Can increase anxiety at higher doses
- Appetite suppression is common side effect
- FDA approved for narcolepsy, shift work disorder
- Well-studied with extensive Western RCT data
- Can impair sleep if taken late in the day
Stack note: Some users combine Bromantane (motivation layer) + Modafinil (focus layer). This is anecdotal — no clinical data exists for the combination. If combining, start at low doses of each to assess tolerance and cardiovascular response.
Dosing Protocols
Community-reported dosing based on the Russian clinical literature and anecdotal use. These are not medical prescriptions.
- Dose: 25–50mg per day
- Can be taken daily at this range
- Best taken in the morning with or without food
- Fat-soluble — absorbs better with a small meal
- Effects: anxiety reduction, baseline mood improvement
- Onset: 1–3 days, full effect in 1–2 weeks
- Dose: 75–100mg per day
- Cycle 3x/week (M/W/F or similar)
- Standard cycling: 4–8 weeks on, 4 weeks off
- Higher doses increase stimulant profile
- Best for cognitive performance demands
- Monitor for overstimulation (rare but possible)
Key difference from stimulants: Bromantane works via enzyme upregulation — effects build gradually over days. It doesn't provide an immediate "kick" like caffeine or modafinil. Legal status: Not FDA approved. Banned by WADA for competitive sport. Sold as a research chemical in most jurisdictions. WADA Banned OTC Research Chem
Study Citations
Primary research behind the data on this page. Click PMID links to read full papers on PubMed.
Self-Assessment
Who Researches Bromantane?
This Research Is Commonly Explored By People Who...
- Are interested in actoprotectors — compounds that enhance physical performance without traditional stimulant mechanisms
- Want to understand bromantane's unique dopamine and serotonin synthesis upregulation (not reuptake inhibition)
- Are researching anxiolytic nootropics that may reduce anxiety while improving motivation
- Are curious about Russian pharmaceutical research and compounds with clinical use outside Western markets
- Want to compare bromantane's mechanism with conventional stimulants and antidepressants
This Research May Not Be Relevant If...
- You're looking for an FDA-approved medication — bromantane is not approved in the US or EU
- You want extensive long-term safety data — most studies are from Russian clinical use with limited Western replication
- You're a competitive athlete — bromantane is on WADA's prohibited list
Want the Complete Protocol Guide?
Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.
Get the Guide →
Key Takeaways
An honest assessment of where Bromantane research stands.
- Upregulates tyrosine hydroxylase — increases dopamine synthesis sustainably
- Simultaneously anxiolytic + psychostimulant — unique dual mechanism
- Used by Soviet military and Russian Olympic athletes (1990s)
- WADA banned in 1996 after widespread performance-enhancing use
- Approved as Ladasten in Russia for asthenic syndrome
- Non-addictive, no tolerance at standard doses in research
- No neurotoxicity observed in animal studies
- No Western RCT data — all clinical research from Russia
- Long-term safety in humans not established beyond Russian studies
- Optimal dosing protocols for cognitive enhancement (not just clinical use)
- Interaction profile with other nootropics or pharmaceuticals
- Whether enzyme upregulation has a ceiling effect or sustained benefit
- Purity and quality consistency from research chemical suppliers
🔬 Verified Research Source
Third-party tested compounds from Swiss Chems — one of the most trusted research suppliers.
Affiliate link — supports HighPeptides at no extra cost. All Swiss Chems products include third-party lab testing certificates.
🛒 Recommended Products
Precursor nutrients and support supplements for the dopamine/serotonin synthesis pathways Bromantane upregulates.
Affiliate links help support HighPeptides at no extra cost to you.
Related Resources
🔗 Related Resources
This page is for educational and informational purposes only. It is not medical advice. Bromantane (Bromantan/Ladasten) is not FDA approved for human use in the United States. It is classified as a banned substance by the World Anti-Doping Agency (WADA) and is prohibited in competitive sport. Research data primarily comes from Russian institutions; independent Western replication is limited. Always consult a qualified healthcare provider before starting any new substance. HighPeptides does not sell Bromantane or endorse its use outside of legitimate research and legal contexts.